Status:

COMPLETED

Effects of Myofunctional Therapy With an Application in Severe Apnea/Hypopnea Sleep Obstructive Syndrome (MTASSAOS)

Lead Sponsor:

Quironsalud

Conditions:

Obstructive Sleep Apnea-hypopnea Syndrome

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

• Background and study aims: Obstructive sleep apnea is a potentially serious sleep disorder. It causes breathing to stop and start repeatedly during sleep. There are several types of sleep apnea, the...

Detailed Description

INTRODUCTION Obstructive sleep apnea/hypopnea syndrome (OSAHS) has become one of the more serious health problems worldwide (Mendes et al., 2014). Because of its relationship with obesity, its prevale...

Eligibility Criteria

Inclusion

  • Age between 18-75 years
  • Recently diagnosed with severe sleep apnea and do not have any previous experience or information with this pathology
  • Consent signed

Exclusion

  • BMI \> 40 kg/m²
  • Inability to fill up questionnaires
  • Severe drug or alcohol abuse
  • Hypnotic medication
  • Not controlled coronary disease
  • Decompensated Heart failure
  • Stroke
  • Systemic Disease associated with inflammatory diagnosed entity (arthritis, sarcoidosis, vasculitis, lupus…)
  • Neuromuscular disease (like Duchenne)
  • Craniofacial deformities.
  • Active oncologic process.
  • Any antecedents of MT treatment or other treatment for sleep apnea could affect study results of the study (surgery, Mandibular Advancement Device (MAD) or CPAP).
  • Once the patient accepted and signed consent and met inclusion criteria, they will be attended by Ent specialist to rule out:
  • Severe upper airway obstruction (Complete nose obstruction, Tonsils grade IV/IV )
  • Presence of tongue tie (Marchesani protocol) with limitation of tongue movements
  • Antecedents or presence of temporomandibular joint disorders

Key Trial Info

Start Date :

March 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2020

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04438785

Start Date

March 1 2019

End Date

September 30 2020

Last Update

February 11 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hospital Quironsalud Campo de Gibraltar

Los Barrios, Cadiz, Spain, 11379

2

Hospital Quironsalud Marbella

Marbella, Malaga, Spain, 29603